These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26516790)

  • 21. Structural Variabilities in β-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for β-Lactam Antibiotic and β-Lactamase Inhibitor Susceptibilities.
    Singhal N; Srivastava A; Kumar M; Virdi JS
    PLoS One; 2014; 10(4):e0123564. PubMed ID: 25919756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
    Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
    Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
    Li XZ; Plésiat P; Nikaido H
    Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Common Platform for Antibiotic Dereplication and Adjuvant Discovery.
    Cox G; Sieron A; King AM; De Pascale G; Pawlowski AC; Koteva K; Wright GD
    Cell Chem Biol; 2017 Jan; 24(1):98-109. PubMed ID: 28017602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospects for new antibiotics: a molecule-centered perspective.
    Walsh CT; Wencewicz TA
    J Antibiot (Tokyo); 2014 Jan; 67(1):7-22. PubMed ID: 23756684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial efflux pump inhibition.
    Kaatz GW
    Curr Opin Investig Drugs; 2005 Feb; 6(2):191-8. PubMed ID: 15751743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations.
    Sun J; Deng Z; Yan A
    Biochem Biophys Res Commun; 2014 Oct; 453(2):254-67. PubMed ID: 24878531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New screens and targets in antibacterial drug discovery.
    Falconer SB; Brown ED
    Curr Opin Microbiol; 2009 Oct; 12(5):497-504. PubMed ID: 19651534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates.
    Ghisalberti D; Mahamoud A; Chevalier J; Baitiche M; Martino M; Pagès JM; Barbe J
    Int J Antimicrob Agents; 2006 Jun; 27(6):565-9. PubMed ID: 16707249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial histidine kinases as novel antibacterial drug targets.
    Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
    ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial efflux pump inhibitors.
    Kamicker BJ; Sweeney MT; Kaczmarek F; Dib-Hajj F; Shang W; Crimin K; Duignan J; Gootz TD
    Methods Mol Med; 2008; 142():187-204. PubMed ID: 18437315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New approaches to antimicrobial discovery.
    Lewis K
    Biochem Pharmacol; 2017 Jun; 134():87-98. PubMed ID: 27823963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial cell division as a target for new antibiotics.
    Sass P; Brötz-Oesterhelt H
    Curr Opin Microbiol; 2013 Oct; 16(5):522-30. PubMed ID: 23932516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tackling antimicrobial resistance by exploring new mechanisms of antibiotic action.
    Matos de Opitz CL; Sass P
    Future Microbiol; 2020 Jun; 15():703-708. PubMed ID: 32648783
    [No Abstract]   [Full Text] [Related]  

  • 36. A call for antibiotic alternatives research.
    Stanton TB
    Trends Microbiol; 2013 Mar; 21(3):111-3. PubMed ID: 23473628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.
    Lynch AS
    Biochem Pharmacol; 2006 Mar; 71(7):949-56. PubMed ID: 16290174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of aspirin on antibiotic susceptibility.
    Zimmermann P; Curtis N
    Expert Opin Ther Targets; 2018 Nov; 22(11):967-972. PubMed ID: 30244614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active efflux, a common mechanism for biocide and antibiotic resistance.
    Levy SB
    J Appl Microbiol; 2002; 92 Suppl():65S-71S. PubMed ID: 12000614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of antibiotic resistance.
    Wright GD
    Chem Commun (Camb); 2011 Apr; 47(14):4055-61. PubMed ID: 21286630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.